Type of SCS | p value | ||
---|---|---|---|
HR-embedded N (Col %) | CHC-embedded N (Col %) | ||
Total | 305 (43.5) | 164 (23.4) | |
Age, median (IQR) | 37 (30–44) | 40.5 (34–49.5) | < 0.001 |
Gender | 0.732 | ||
Cisgender women | 103 (34.0) | 50 (30.5) | |
Cisgender men | 187 (61.7) | 106 (64.6) | |
Transgender or gender-diverse | 13 (4.3) | 8 (4.9) | |
Race/ethnicity | 0.968 | ||
Indigenous | 98 (32.1) | 53 (32.5) | |
Racialized, non-indigenous | 38 (12.5) | 19 (11.7) | |
White | 169 (55.4) | 91 (55.8) | |
Education | 0.948 | ||
High school or less | 203 (66.8) | 110 (67.1) | |
Any post-secondary | 101 (33.2) | 54 (32.9) | |
Housing** | 0.532 | ||
Any unstable | 260 (85.2) | 134 (81.7) | |
Stable | 20 (6.6) | 13 (7.9) | |
Missing | 25 (8.2) | 17 (10.4) | |
Drug injected most often** | < 0.001 | ||
Fentanyl | 191 (62.6) | 70 (42.7) | |
Heroin | 12 (3.9) | 21 (12.8) | |
Prescription opioids | 9 (3.0) | 21 (12.8) | |
Crystal methamphetamine | 61 (20.0) | 22 (13.4) | |
Cocaine or crack/rock cocaine | 15 (4.9) | 21 (12.8) | |
Other | 14 (4.6) | 7 (4.3) | |
Injections per day (Mean, SD)** | 4.9 (4.2) | 4.8 (3.7) | 0.716 |
Currently receiving medication for substance use | 113 (37.2) | 63 (38.7) | 0.753 |
Frequency of any SCS use** | < 0.001 | ||
Daily or more | 151 (49.5) | 42 (25.6) | |
Once a week or more—less than daily | 110 (36.1) | 80 (48.8) | |
Less than weekly | 40 (13.1) | 39 (23.8) |